CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Cardinal Health

Brent Stutz, SVP of Commercial Technologies

Fusing Pharma Technology and Healthcare

Brent Stutz

Brent Stutz

The Evolution of Pharmacy industry


For years the issue of non-adherence and non-compliance and their economic impact has been discussed at length. However, as data has become more accessible on a greater scale, more effort has been focused on the importance of producing a consensus for standards measuring adherence and the burden that non-adherence places on the healthcare system.


Pharmacies are under pressure to respond to Medicare’s movement toward quality measures for determining reimbursement. Inclusion in payer networks could also be at risk.


In addition, pharmacists’ reimbursement for clinical-based services is gaining momentum, primarily in the form of Medication Therapy Management and other patient-facing services offered by pharmacists. Challenges for the pharmacist include identifying patients in need of these services, understanding how to successfully approach those candidates, as well as workflow changes, time allocation and acceptance of these services by patients. Meanwhile, payers are watching closely for evidence of the impact of interventions. While results won’t happen overnight and will require patience from everyone involved, the pharmacy should rely on data to improve its reimbursements and quality of care.


Finally, as we encourage patients to take more ownership of their healthcare, and encourage adherence, we must support the continued development of new technologies and patient engagement methods.


Obstacles in Pharmacy industry


I work in the Cardinal Health innovation center, Fuse, located in Dublin, Ohio; I work among 100+ software developers, UI/UX designers, marketing research and business analysts. Honestly, it is a concentration of some of the brightest people that I’ve ever been with and a seriously fun place to work. The people are passionate about providing technology-related solutions for healthcare customers—and ultimately, patients.


However, we don’t produce software or technology solutions just for the sake of producing something that we think works. We collaborate with customers to identify what the pain points really are. We build something for users that make sense to them and solve their problems. Then, we update it, and update it again. We can build software and hardware solutions that look really cool and are feature-packed and function well, but if—at its core—it doesn’t connect patients and providers, promote health and wellness, reduce cost and complexity or work to eliminate waste in healthcare, we haven’t done our jobs.


Some challenges that may impact the pharmacy extend to other areas of healthcare. I recently read an article outlining the very real prospect of a nurse shortage in the U.S. and that impact will be felt across many healthcare sectors. To think that pharmacy will be immune from any impact is naïve; however, it represents an opportunity to offer expertise in serving the patients who will feel the most pain from the impact. Pharmacy needs to be well positioned to seize this opportunity.


To ensure the pharmacist is well positioned and practicing at the top of their license, there has been progress at the state level in pushing provider status legislation for pharmacists. However, there is plenty more work to do at the national level.


Required Skill Sets for Leaders in this Landscape


Leaders, to be successful in pharmacy, need to continue to be professional and honest with those they serve.


Given the rapid pace of change in technology, being agile and adaptable is more of a requirement than ever before. People developing healthcare solutions need to get out and talk to their customers, ask questions and listen to their answers. We have to stop assuming we have solutions to all problems before knowing what the problems are.


Exciting Future Technology Innovations


Augmented and virtual reality, hands down. Currently, the vast majority of applications are focused on gaming and entertainment, so the field is truly wide open for development in healthcare.


The limitations of the applications are difficult to get my head around; if there are limitations, they might only be in the form of processing power and human resources to code the applications, but those are usually short-lived and are good limitations to chase.


Imagine using VR/AR to treat depression and anxiety, relaxation/ distraction techniques for pain reduction, process and workflow creation and evaluation, scenario-based training, and utilizing machine learning algorithms to create new training scenarios. The possibilities are vast, and limited only by imagination and resources. Today, immersive training requires expensive tangible elements and limited occupancy space. VR and AR can allow for a similar immersive experience with unlimited occupancy along with virtualized elements.


Technology as a Driving Force


I work in an innovation center surrounded by developers and designers, so most of my work life is driven by technology. I consult internally on multiple projects, contributing from clinical and pharmacy regulatory perspectives.


Most of us are surrounded by technology quite literally in the cars we drive, our smartphones and televisions, integration into our home HVAC systems, and in our wearable technologies, which produces this immersive sense of being always connected. For the most part, these technologies have been very beneficial and fundamentally changed the way we communicate and stay connected with one another. For example, consider how we buy and listen to music, how we book travel, and how we get our news. We can track our nutrition; compete with friends for fitness goals, post vacation pictures and, of course, cat videos on social media. Running low on detergent? Press a button. Need razors? Fire up your app and change your delivery schedule.


However, advances in technology can also produce unintended consequences. For example, manual Drug Utilization Review (DUR) is a losing proposition from every angle for a pharmacist. Automated DUR programs are great, but they can produce alert fatigue, and interactions and inappropriate doses can be overlooked. In hands-on care settings, telemetry units produce thousands of alerts daily, producing this same danger of alert fatigue. The unintended consequences of advances in technology require real solutions in themselves. Will those solutions produce their own unintended consequences? Making the distinction between benefiting from technology and relying on technology is an important one to make and sometimes, we need to just put it down for a while and get outside.


At Fuse, we’re developing software and hardware technology to give retail pharmacists some much-needed visibility into patients’ medication-taking patterns with the goal of connecting patients with their pharmacists to facilitate regular, focused, data-driven conversations about their wellness.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/cxoinsight/fusing-pharma-technology-and-healthcare-nwid-27.html